Abstract:Approximately 70–80% of newborns less than 28 weeks' gestational age require pharmacologic and/or surgical intervention to close a hemodynamically significant patent ductus arteriosus (PDA). Indomethacin has been the pharmacologic treatment of choice and has also been used prophylactically in very premature neonates to prevent PDA. The drug, however, is associated with renal and gastrointestinal adverse effects. In July 2006, intravenous ibuprofen lysine became available in the United States for treatment of hemodynamically significant PDA. The mechanism of action for both indomethacin and ibuprofen lysine is through inhibition of prostaglandin synthesis, resulting in ductal constriction. Both drugs appear to be equally efficacious in closing echocardiographically confirmed PDA. Ibuprofen lysine has demonstrated significantly less effects on cerebral, renal, and mesenteric blood flow in premature neonates when compared with indomethacin. A transient but significant increase in serum creatinine concentration, decrease in urine output, and increase in frequency of oliguria were observed with indomethacin when compared with ibuprofen lysine. However, the rate of reopening of the ductus after pharmacologic closure and the need for rescue therapy were not different between the two drugs. In addition, no differences were noted in other outcomes such as frequency of intraventricular hemorrhage, necrotizing enterocolitis, or chronic lung disease, as well as in duration of mechanical ventilation and length of hospital stay. When administered prophylactically, ibuprofen lysine did not prevent intraventricular hemorrhage nor provide any neurodevelopmental benefits. In addition, ibuprofen lysine has not been adequately studied in neonates of 27 weeks' gestational age or younger. Ibuprofen lysine is as efficacious as indomethacin in treating hemodynamically significant PDA in neonates greater than 27 weeks' gestational age.

GPU-accelerated extractive multi-document text summarization using decomposition-based multi-objective differential evolution

Ibuprofen Lysine for the Prevention and Treatment of Patent Ductus Arteriosus

Advancing automatic text summarization: Unleashing enhanced binary multi-objective grey wolf optimization with mutation

COSUM: Text summarization based on clustering and optimization

Multi-Modal Summary Generation using Multi-Objective Optimization

AWESOME: GPU Memory-constrained Long Document Summarization using Memory Mechanism and Global Salient Content

MOEA/D: A Multiobjective Evolutionary Algorithm Based on Decomposition

PDSum: Prototype-driven Continuous Summarization of Evolving Multi-document Sets Stream

Extractive Single-Document Summarization Based on Global-Best Harmony Search and a Greedy Local Optimizer

A deep learning framework for multi-document summarization using LSTM with improved Dingo Optimizer (IDO)

GPU Based Differential Evolution: New Insights and Comparative Study

Multi-Dimensional Optimization for Text Summarization via Reinforcement Learning

GPU-based parallel multi-objective particle swarm optimization

Compressive Document Summarization Via Sparse Optimization.

Decomposition Multi-Objective Evolutionary Optimization: From State-of-the-Art to Future Opportunities

Towards Large-Scale Evolutionary Multi-Tasking: A GPU-Based Paradigm

Enhancing extractive text summarization using natural language processing with an optimal deep learning model

Decomposition Multi-Objective Evolutionary Algorithm Based on Adaptive Neighborhood Adjustment Strategy

Evolutionary Multi-objective Optimization Made Faster by Sequential Decomposition

A survey of decomposition approaches in multiobjective evolutionary algorithms

Improved multi-objective differential evolution algorithm based on a decomposition strategy for multi-objective optimization problems